Investors - Press Releases
<< Back |
View printer-friendly version |
Tabula Rasa HealthCare Plans for a 30% Increase in Medicare Lives Receiving Medication Therapy Management Services for 2018
MTM programs are designed to enhance a more personalized approach to medication management with the goal of optimizing the effectiveness and safety of medication regimens. Under the new agreements, SinfoníaRx’s clinical pharmacists will utilize SinfoníaRx’s proprietary software platform, RxCompanion™, to enhance how
The average
“RxCompanion is a highly customizable and scalable platform designed to identify and help resolve medication related problems resulting in enhanced patient care and safety, as well as reduced spending,” said
The new agreements began on
About
TRHC (NASDAQ:TRHC) is a leader in providing patient-specific, data-driven technology and solutions that enable health care organizations to optimize medication regimens to improve patient outcomes, reduce hospitalizations, lower healthcare costs and manage risk. TRHC provides solutions for a range of payers, providers and other healthcare organizations. SinfoníaRx is a
Forward-Looking Statements
This press release includes forward-looking statements that we believe to be reasonable as of today’s date including statements regarding the anticipated number of
Media Contact
Dianne Semingson
dsemingson@TRHC.com
T: 215-870-0829
Investors
Bob East or Asher Dewhurst
443-213-0500
tabularasa@westwicke.com